版本:
中国

BRIEF-Aethlon Medical announces the conclusion of hemopurifier clinical study

March 13 Aethlon Medical Inc

* Aethlon Medical announces the conclusion of hemopurifier clinical study

* Aethlon Medical - in feasibility study, hemopurifier observed to be well tolerated in ESRD volunteers who were also infected with hepatitis c virus

* Aethlon Medical Inc says no device-related adverse events were observed in enrolled subjects who met study inclusion/exclusion criteria

* Aethlon Medical Inc - company also seeks to advance hemopurifier under provisions of 21st century cures act, which was signed into law in Dec 2016 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐